A Study of MK-0616 in Healthy Adult Participants (MK-0616-009)
type: MedicalStudy
description: An Open-Label, Randomized, Single-Dose, 3-Period, Crossover Study to Evaluate the Comparative Bioavailability of MK-0616 Capsules and Tablet Formulations in Healthy Participants
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2022-10-25
end date: 2022-12-29
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT06592339
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Merck Sharp & Dohme LLC
study subject: Hypercholesterolemia
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Hypercholesterolemia

AI Analytics
type: Organization